2020 annual financial data
Spyre Therapeutics 2020 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -81,481,000 USD and net income was -80,893,000 USD.
Operating cash flow was -75,775,000 USD.
Get free Spyre Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -81,481,000 USD
- Net income
- -80,893,000 USD
- Operating cash flow
- -75,775,000 USD